210 related articles for article (PubMed ID: 23176550)
1. In vitro development and analysis of Escherichia coli and Shigella boydii azithromycin-resistant mutants.
Gomes C; Pons MJ; Magallon-Tejada A; Durand D; Lluque A; Mosquito S; Riveros M; Mercado E; Prada A; Ochoa TJ; Ruiz J
Microb Drug Resist; 2013 Apr; 19(2):88-93. PubMed ID: 23176550
[TBL] [Abstract][Full Text] [Related]
2. Which mechanisms of azithromycin resistance are selected when efflux pumps are inhibited?
Gomes C; Martínez-Puchol S; Durand D; Lluque A; Mosquito S; Ochoa TJ; Ruiz J
Int J Antimicrob Agents; 2013 Oct; 42(4):307-11. PubMed ID: 23871456
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Shigella Species Azithromycin CLSI Epidemiological Cutoff Values and Macrolide Resistance Genes.
Salah M; Shtayeh I; Ghneim R; Al-Qass R; Sabateen A; Marzouqa H; Hindiyeh M
J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30700507
[TBL] [Abstract][Full Text] [Related]
4. Fitness and molecular mechanisms of resistance to rifaximin in in vitro selected Escherichia coli mutants.
Pons MJ; Mensa L; Gascón J; Ruiz J
Microb Drug Resist; 2012 Aug; 18(4):376-9. PubMed ID: 21711150
[TBL] [Abstract][Full Text] [Related]
5. Azithromycin resistance levels and mechanisms in Escherichia coli.
Gomes C; Ruiz-Roldán L; Mateu J; Ochoa TJ; Ruiz J
Sci Rep; 2019 Apr; 9(1):6089. PubMed ID: 30988366
[TBL] [Abstract][Full Text] [Related]
6. Genetic diversity and antibiotic resistance in Shigella dysenteriae and Shigella boydii strains isolated from children aged <5 years in Egypt.
El-Gendy AM; Mansour A; Weiner MA; Pimentel G; Armstrong AW; Young SY; Elsayed N; Klena JD
Epidemiol Infect; 2012 Feb; 140(2):299-310. PubMed ID: 21470441
[TBL] [Abstract][Full Text] [Related]
7. Multiple Mechanisms Confer Resistance to Azithromycin in
Nusrin S; Asad A; Hayat S; Islam B; Begum R; Nabila FH; Islam Z
Microbiol Spectr; 2022 Aug; 10(4):e0074122. PubMed ID: 35876510
[No Abstract] [Full Text] [Related]
8. Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi, Vietnam.
Nguyen TV; Le PV; Le CH; Weintraub A
Antimicrob Agents Chemother; 2005 Feb; 49(2):816-9. PubMed ID: 15673777
[TBL] [Abstract][Full Text] [Related]
9. High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes.
Chisholm SA; Dave J; Ison CA
Antimicrob Agents Chemother; 2010 Sep; 54(9):3812-6. PubMed ID: 20585125
[TBL] [Abstract][Full Text] [Related]
10. Relevant role of efflux pumps in high levels of rifaximin resistance in Escherichia coli clinical isolates.
Gomes C; Ruiz L; Pons MJ; Ochoa TJ; Ruiz J
Trans R Soc Trop Med Hyg; 2013 Sep; 107(9):545-9. PubMed ID: 23843564
[TBL] [Abstract][Full Text] [Related]
11. [Resistance to azithromycin of Neisseria gonorrhoeae strains isolated in Poland in 2012-2013 years].
Młynarczyk-Bonikowska B; Kujawa M; Młynarczyk G; Malejczyk M; Majewski S
Med Dosw Mikrobiol; 2014; 66(3-4):209-14. PubMed ID: 25804074
[TBL] [Abstract][Full Text] [Related]
12. Development of Escherichia coli rifaximin-resistant mutants: frequency of selection and stability.
Ruiz J; Mensa L; Pons MJ; Vila J; Gascon J
J Antimicrob Chemother; 2008 May; 61(5):1016-9. PubMed ID: 18325895
[TBL] [Abstract][Full Text] [Related]
13. Decreased Susceptibility to Azithromycin Among Clinical Shigella Isolates from China.
Zhang C; Zhang R; Yu Q; Chu X; Sun J; Liu Q
Microb Drug Resist; 2017 Jul; 23(5):596-601. PubMed ID: 27841958
[TBL] [Abstract][Full Text] [Related]
14. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
Pasquali F; Manfreda G
Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
[TBL] [Abstract][Full Text] [Related]
15. Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps.
Kothary V; Scherl EJ; Bosworth B; Jiang ZD; Dupont HL; Harel J; Simpson KW; Dogan B
Antimicrob Agents Chemother; 2013 Feb; 57(2):811-7. PubMed ID: 23183443
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of shigellosis in Lagos, Nigeria: trends in antimicrobial resistance.
Iwalokun BA; Gbenle GO; Smith SI; Ogunledun A; Akinsinde KA; Omonigbehin EA
J Health Popul Nutr; 2001 Sep; 19(3):183-90. PubMed ID: 11761772
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility trends among Escherichia coli and Shigella spp. isolated from rural Egyptian paediatric populations with diarrhoea between 1995 and 2000.
Putnam SD; Riddle MS; Wierzba TF; Pittner BT; Elyazeed RA; El-Gendy A; Rao MR; Clemens JD; Frenck RW
Clin Microbiol Infect; 2004 Sep; 10(9):804-10. PubMed ID: 15355411
[TBL] [Abstract][Full Text] [Related]
18. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV
J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614
[TBL] [Abstract][Full Text] [Related]
19. Development and analysis of furazolidone-resistant Escherichia coli mutants.
Martínez-Puchol S; Gomes C; Pons MJ; Ruiz-Roldán L; Torrents de la Peña A; Ochoa TJ; Ruiz J
APMIS; 2015 Aug; 123(8):676-81. PubMed ID: 26011027
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
